Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 03, 2019 07:30 ET | Source: Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals and SunGen Pharma File ANDA for an Antibiotic

NORTHVALE, N.J., Jan. 03, 2019 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB: ELTP) a specialty pharmaceutical company developing abuse-deterrent opioids and...
December 10, 2018 07:30 ET | Source: Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals and SunGen Pharma Receive FDA Approval for Generic Adderall®

NORTHVALE, N.J., Dec. 10, 2018 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB: ELTP) a specialty pharmaceutical company developing abuse-deterrent opioids and...
February 08, 2018 11:32 ET | Source: Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals and SunGen Pharma File ANDA

NORTHVALE, N.J., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB:ELTP) a specialty pharmaceutical company developing abuse-deterrent opioids and niche...
January 10, 2018 08:00 ET | Source: Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals Reports Positive Topline Results from Pivotal Bioequivalence Studies for an Extended-Release Generic

NORTHVALE, N.J., Jan. 10, 2018 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB:ELTP) today reported positive topline results from pivotal bioequivalence studies for...
May 30, 2017 08:42 ET | Source: Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals Reports Positive Topline Results from a Pivotal Bioequivalence Study

NORTHVALE, N.J., May 30, 2017 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB:ELTP) today reported positive topline results from pivotal bioequivalence studies...